EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic and epidemiological characteristics of the spread of human metapneumovirus in Bulgaria, 2023–2025

I Trifonova, N Korsun, D Pavlova, Zh Getsova, N Rukmanski, T Valkov, P Velikov, I Ivanov, T Dakov, D Ivanov, Y Uzunova, I Christova

Frontiers in Public Health · 2026

DOI: 10.3389/fpubh.2026.1834413 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Public Health, 2026. Verfasst von I Trifonova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology, National Centre of Infectious and Parasitic Diseases, National Laboratory "Influenza and ARD", Sofia, Bulgaria. Hauptthemen laut MEDLINE: Metapneumovirus, Paramyxoviridae Infections, Respiratory Tract Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Human metapneumovirus (hMPV) can cause severe respiratory illnesses such as bronchitis, bronchiolitis, and pneumonia, particularly in young children, older adults, and individuals with weakened immune systems. This study aimed to assess hMPV circulation patterns, including seasonal and demographic distribution, track genetic evolution and mutations in surface proteins, and explore associations with clinical severity.

Methods

From early 2023 to November 2025, Bulgaria’s National Reference Laboratory tested nasopharyngeal samples from 6,958 patients with respiratory symptoms using an in-house multiplex real-time PCR method that detected 11 viruses. Positive hMPV samples were sequenced and analyzed phylogenetically.

Results

A study conducted 3 years after the COVID-19 pandemic found that 1.4% (97 patients) tested positive for hMPV, with most being mono-infected (85.6%) and others co-infected, primarily with rhinovirus and adenovirus. The infection rate was highest in children under 5 (2.8%), especially infants and toddlers (2.2%), compared to 0.4% in those over 65 ( p < 0.05). Common symptoms in 56% of hMPV-positive patients included cough (50%), fever (38%), and rhinitis (21.2%). Among 94 patients with respiratory involvement, 34% had upper respiratory tract infections (URTs), and 55% had lower respiratory tract infections (LRTs), with bronchiolitis (46%) and pneumonia (30.7%) being common. Hospitalized patients had a 19% rate of severe acute respiratory infection (SARI), higher than the 7.3% for other viruses. Sequencing revealed genotypes A and B in similar proportions, with subclade B2 being the most common at 41.3%. However, in 2025, subclade A2b2 represented 52% of the samples. The A2b2 subclade in children under 5 showed a higher incidence of lower respiratory complications ( p < 0.05), while genotype B was linked to an increased risk of SARI at higher viral loads ( p < 0.05).

Conclusion

The findings confirm that hMPV is a significant respiratory pathogen for young children, showing substantial genetic diversity in Bulgaria, with lineage A2b2 becoming more prevalent in 2025. Host age and viral genetics may influence disease presentation. These results highlight the clinical burden of hMPV and emphasize the need for preventive strategies, including vaccine development for high-risk children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetapneumovirusParamyxoviridae InfectionsRespiratory Tract InfectionsHumansBulgariaInfantFemaleChild, PreschoolMaleChildAdultAdolescentMiddle AgedPhylogenyAgedYoung AdultSeasons

Stichwörter der Autor:innen

human metapneumoviruslower respiratory tract infectionsnext-generation sequencingphylogenetic analysissevere acute respiratory infections

Autor:innen und Institutionen

  • Department of Virology, National Centre of Infectious and Parasitic Diseases, National Laboratory "Influenza and ARD", Sofia, Bulgaria.
  • Center of Competence "ImmunoPathogen", Sofia, Bulgaria.
  • Department for Infectious Diseases, Parasitology and Tropical Medicine, Medical University of Sofia, Sofia, Bulgaria.
  • Affiliate "Prof. Dr. Ivan Mitev" Vratsa, Medical University of Sofia, Sofia, Bulgaria.
  • University Hospital "Lozenetz", Sofia, Bulgaria.
  • Infectious Disease Hospital "Prof. Ivan Kirov", Sofia, Bulgaria.

Zitieren

APA

Trifonova, I., Korsun, N., Pavlova, D., Getsova, Z., Rukmanski, N., Valkov, T., Velikov, P., Ivanov, I., Dakov, T., Ivanov, D., Uzunova, Y., & Christova, I. (2026). Genetic and epidemiological characteristics of the spread of human metapneumovirus in Bulgaria, 2023–2025. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2026.1834413

Vancouver

Trifonova I, Korsun N, Pavlova D, Getsova Z, Rukmanski N, Valkov T, et al. Genetic and epidemiological characteristics of the spread of human metapneumovirus in Bulgaria, 2023–2025. Frontiers in Public Health. 2026. doi:10.3389/fpubh.2026.1834413

BibTeX
@article{Trifonova2026,
  author = {Trifonova, I and Korsun, N and Pavlova, D and Getsova, Zh and Rukmanski, N and Valkov, T and Velikov, P and Ivanov, I and Dakov, T and Ivanov, D and Uzunova, Y and Christova, I},
  title = {Genetic and epidemiological characteristics of the spread of human metapneumovirus in Bulgaria, 2023–2025},
  journal = {Frontiers in Public Health},
  year = {2026},
  doi = {10.3389/fpubh.2026.1834413}
}
Kostenlos starten →